학술논문

Treatment of critical bone defects using calcium phosphate cement and mesoporous bioactive glass providing spatiotemporal drug delivery
Document Type
article
Source
Bioactive Materials, Vol 28, Iss , Pp 402-419 (2023)
Subject
Drug delivery
3D plotting
Alveolar cleft defect
Calcium phosphate cement
Mesoporous bioactive glass
Materials of engineering and construction. Mechanics of materials
TA401-492
Biology (General)
QH301-705.5
Language
English
ISSN
2452-199X
Abstract
Calcium phosphate cements (CPC) are currently widely used bone replacement materials with excellent bioactivity, but have considerable disadvantages like slow degradation. For critical-sized defects, however, an improved degradation is essential to match the tissue regeneration, especially in younger patients who are still growing. We demonstrate that a combination of CPC with mesoporous bioactive glass (MBG) particles led to an enhanced degradation in vitro and in a critical alveolar cleft defect in rats. Additionally, to support new bone formation the MBG was functionalized with hypoxia conditioned medium (HCM) derived from rat bone marrow stromal cells. HCM-functionalized scaffolds showed an improved cell proliferation and the highest formation of new bone volume. This highly flexible material system together with the drug delivery capacity is adaptable to patient specific needs and has great potential for clinical translation.